Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics

Eli Lilly, the Indianapolis-based drug giant, said Monday that it will purchase Loxo Oncology, a tiny startup, for $8 billion in cash to gain access to the company’s cancer medicines, one of which is on the market.